SMAD6 and neoplasm: Moreover, although both Ad-CMV-Tom and Ad-Smad6 treated tumour exhibited a similar number of blood vessels per field, the percentage of blood vessels with endothelialised cells decreased nearly 3-fold in the Smad6-treated group when compared with controls (Fig. 5H-5I).